(Q42543595)

2 November 2017

title

Aminorex, dexfenfluramine, and primary pulmonary hypertension (English)

1 reference

2 November 2017

Aminorex, Dexfenfluramine, and Primary Pulmonary Hypertension (English)

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00289-8

16 December 2024

author name string

M. S. Kramer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9539893

16 December 2024

D. A. Lane

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9539893

16 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9539893

16 December 2024

publication date

1 April 1998

1 reference

2 November 2017

April 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9539893

full work available at URL

16 December 2024

https://api.elsevier.com/content/article/PII:S0895435697002898?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00289-8

https://api.elsevier.com/content/article/PII:S0895435697002898?httpAccept=text/plain

16 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00289-8

Journal of Clinical Epidemiology

16 December 2024

published in

1 reference

2 November 2017

volume

51

1 reference

2 November 2017

issue

4

1 reference

2 November 2017

page(s)

361-364

1 reference

Primary pulmonary hypertension and cirrhosis: are they related?

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Primary pulmonary hypertension and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Pulmonary hypertension and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Familial primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Aminorex and the pulmonary circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Drug-induced Pulmonary Hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Primary pulmonary hypertension and fenfluramine use

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Drug-induced pulmonary hypertension: must history repeat itself?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Estimability and estimation in case-referent studies

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Neurobiology of an anorectic drug: fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

MAO-inhibitory properties of anorectic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Fluoxetine is a safer alternative to fenfluramine in the medical treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900289-8

7 January 2021

Release of Platelet 5-Hydroxytryptamine by Some Anorexic and Other Sympathomimetics and their Acetyl Derivatives

26

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00289-8

Effect of serotonin re-uptake inhibition by fluoxetine on body weight and spontaneous food choice in obesity

16 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00289-8

Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline

16 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00289-8

16 December 2024

Identifiers

1 reference

2 November 2017

1 reference